Madrigal Pharmaceuticals Inc (MDGL)
308.71
+15.30
(+5.21%)
USD |
NASDAQ |
Dec 20, 16:00
307.91
-0.80
(-0.26%)
Pre-Market: 20:00
Madrigal Pharmaceuticals Price to Book Value: 8.664 for Dec. 20, 2024
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Corcept Therapeutics Inc | 8.435 |
| 89bio Inc | 2.466 |
| ADMA Biologics Inc | 17.74 |
| Matinas BioPharma Holdings Inc | 0.1757 |
| Viking Therapeutics Inc | 5.166 |
Price to Book Value Related Metrics
| PEG Ratio | -0.4021 |
| Price | 308.71 |
| Earnings Yield | -8.14% |
| Market Cap | 6.733B |
| PEGY Ratio | -0.4021 |